Blood fat testing study in adults with and without type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study measures how “blood fats” move in the body after fasting and controlled eating, comparing people with type 1 diabetes to those without diabetes. It may help researchers understand diabetes-related differences in lipid (fat) handling and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 45 years.
- Your body mass index (BMI) is between 18.5 and under 30.
- If you can get pregnant: you must not be pregnant or breastfeeding.
- For people without diabetes (controls): fasting glucose, 2-hour glucose test, and HbA1c must all be in normal ranges.
- For people with type 1 diabetes: your insulin dose must be stable for at least 8 weeks and your HbA1c must be below 8.0%.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how blood fats (especially HDL cholesterol) differ between people with well-controlled type 1 diabetes and people without diabetes. Researchers want to understand if improving blood sugar control can help improve these protective blood fats.
This study looks at immune (defense system) and blood-sugar changes in people with type 1 diabetes, and in some other diabetes or autoimmune hormone conditions. It includes people who will have a specific abdominal surgery so doctors can safely study lymph node tissue.
This study tests whether using an automated insulin delivery system (a smart pump that adjusts insulin based on sensor readings) can help improve blood sugar control and bone health in adults with Type 1 diabetes who have high and unstable blood sugars.
This study looks at how blood vessels and blood pressure change in children soon after being diagnosed with type 1 diabetes. It may help doctors better understand early vascular risk and how to monitor it.
This study looks at how fat is processed in the body for people with different health conditions, including obesity and type 2 diabetes. It aims to find new ways to improve treatment by understanding these differences.
This study measures “circulating biomarkers” (blood-based signals) in people with type 1 or type 2 diabetes, and in some people without diabetes who test positive for certain diabetes antibodies. The goal is to understand what these blood signals can tell us about diabetes development and progression.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.